Romaine Bostick breaks down the day’s top stories and trading action leading into the close.
Insight and analysis of top stories from our award winning magazine “Bloomberg Businessweek”.
Highlights from a week-long virtual event bringing Bloomberg Businessweek magazine to life. Carol Massar and Tim Stenovec host a look back at the best interviews, discussions and more.
The Stock Market Was So Bad in 2022 Even Hedges Couldn’t Help You
OneCoin Cofounder Pleads Guilty to Fraud for Hyping Fake Crypto
Fed Officials Reinforce Hawkish Message on Need for Higher Rates
Colombia Lifts Key Rate to 20-Year High to Tame Soaring Inflation
US Statistics Agency Says ‘No Evidence’ of Hack on CPI Report
Hedge Fund Traders Seek Shelter From Lula in Bearish Stock Bets
Amazon Cited by OSHA for Failing to Record Warehouse Injuries
Twitter Accused in Lawsuit of Stiffing Software Supplier Owed Millions
Blizzard Brings Back Veteran Designer Amid Gaming Reorganization
GM’s Cruise Robotaxi Unit Faces Safety Probe After Three Accidents
Peru’s Congress Rejects Constitutional Reform to Hold Early Vote
Biden to Tap Joe Kennedy as Special Envoy for Northern Ireland
Michael Burry Says Crypto Audits Are ‘Essentially Meaningless’
How to Prepare for 2023 With Student Loan Relief Unclear
Former Syracuse Star, Knicks Player Louis Orr Dies At 64
Disney’s ‘Avatar’ Sequel Takes In $17 Million in Preview Ticket Sales
2022 Has Not Been Kind to Musk’s Tesla. Exxon Is Catching Up.
New Roommate? Why You Should Make Your Adult Kid Pay Rent
The SEC Wants to Upend the Stock Market. Is It Worth It?
The Future of Work Is Lunch
Hollywood Loves Its Never-Ending Blizzard of Cheap Christmas Movies
Seven Takeaways From Businessweek’s Cocaine-Smuggling Cover Story
Apple Created a Pseudo-Union to Defeat Organizers in Ohio, Complaint Claims
Fatal Work Injuries Reach All-Time High Among Black US Workers
Historic Drought Threatens US, But States Are Nowhere Near a Deal to Share Water
Why Coal Companies Love Bankruptcy
Doctors Are Taking on the Next Public Health Crisis: Mass Shootings
Santa Claus, the Spirit of the Mall, Is Back
San Francisco Mayor Warns of Budget Deficit as Remote Work Hits Revenue
This Week in Crypto: SBF Arrested (Podcast)
Crypto Firm Amber Raises $300 Million to Tackle Damage From FTX
What Crypto’s Decline Means for the Future of Bitcoin ATMs (Podcast)
Pfizer Inc.’s Paxlovid antiviral medication.
Subscriber Benefit
Subscribe
Sign In
Pfizer Inc. cemented a deal first announced in March to sell its antiviral medication Paxlovid in China through a state-owned company, adding to supply of Covid treatments in the country that’s now facing a massive infection surge.
China Meheco Group Co. signed an agreement Wednesday with Pfizer to import and distribute Paxlovid on the mainland, the company said in a filing with the Shanghai Stocks Exchange. The agreement is effective immediately and expires on Nov. 30, 2023, the statement said. Further terms weren’t disclosed.